Effectiveness of Action Observation Therapy in Stroke Patients

NCT06501014 | Completed

• 1 other identifier: KaratayUO3
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to learn the effectiveness of action observation therapy in patients with stroke. The main questions it aims to answer are: Is action observation therapy an effective method in stroke patients? Researchers will compare the results of two action observation-based exercises (home program) with conventional exercise to see whether action observation therapy works in the rehabilitation of stroke patients. Participants: Participants in one group will do action observation-based exercise (home plus conventional exercise for 24 sessions, Patients in the control group will only undergo conventional exercise in addition to routine treatment.

Conditions

Stroke; Rehabilitation

Outcome Measures

Primary Outcomes (3)

• 2 minute walk test

  Patients will be asked to walk 30 meters long on a flat surface for 2 minutes. When the time is up, the distance the patient can walk will be recorded.

  The evaluation will be applied at the baseline and after study completion, an average of 2 months.

• Fugl-Meyer Assessment

  The FMA motor assessments for the lower extremity (minimum score:0 and maximum score 34 points) will be applied. A higher score means the patient's motor movements are better.

  The evaluation will be applied at the baseline and after study completion, an average of 2 months.

• Berg Balance Scale

  The Berg Balance Scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of funcion.

  The evaluation will be applied at the baseline and after study completion, an average of 2 months.

Study Arms (2)

Action Observation Therapy-Experimental Group

EXPERIMENTAL

Patients will be asked to watch the exercises before doing them. For each exercise, patients will first watch the relevant video and do the exercise after the video ends.

Other: Action Observation Therapy-Experimental Group

Conventional Exercises-Control Group

ACTIVE COMPARATOR

Patients will be subjected to conventional exercise only.

Other: Conventional Exercises-Control Group

Interventions

Action Observation Therapy-Experimental Group OTHER

Patients will be asked to watch the exercises before doing them.For each exercise, patients will first watch the relevant video and do the exercise after the video ends.

Action Observation Therapy-Experimental Group

Conventional Exercises-Control Group OTHER

Patients will be subjected to conventional exercise only.

Conventional Exercises-Control Group

Eligibility Criteria

• Age: 40 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Stroke patients in the chronic phase (more than 6 months have passed since the stroke)
• Patients over 40 years of age
• Patients who can stand and walk independently (including those using walking aids)

You may not qualify if:

• Additional disease (neurological, orthopedic, etc.) that may affect motor performance and balance.
• Patients with communication problems
• Patients with mental problems (mini-mental test score \<23)
• Patients aged 85 and over

Sponsors & Collaborators

• KTO Karatay University: lead

Study Sites (1)

KTO Karatay University

Konya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Osman Karaca, PhD

  KTO Karatay University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 8, 2024
• First Posted: July 15, 2024
• Study Start: July 16, 2024
• Primary Completion: September 30, 2025
• Study Completion: September 30, 2025
• Last Updated: December 10, 2025

Record last verified: 2025-10

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)